Corixa Taps Wagg Ed Biosciences Division
Charting the future of public relations
Holmes Report
CEO

Corixa Taps Wagg Ed Biosciences Division

Waggener Edstrom’s bioscience division has been selected to represent Corixa Corporation, which develops immunotherapeutic products for the treatment and prevention of autoimmune diseases, cancer and infectious diseases.

Paul Holmes

PORTLAND, March 28—Waggener Edstrom’s bioscience division has been selected to represent Corixa Corporation. Headquartered in Seattle, Corixa develops immunotherapeutic products for the treatment and prevention of autoimmune diseases, cancer and infectious diseases.
 
Waggener Edstrom Bioscience will develop and execute strategic communications, public relations and investor relations programs. Jenny Moede, vice president and co-founder of Waggener Edstrom Bioscience, will lead the agency’s account team.
 
“We selected Waggener Edstrom because its team understood our business and displayed a strong passion for what we do,” said Jim DeNike, director of corporate communications at Corixa. “We were impressed with the team’s creative outlook and industry experience, and look forward to working with it to develop communications programs that will increase awareness of Corixa.”
View Style:

Load 3 More
comments powered by Disqus